TOC Monitoring in Purelab Pharma Compliance

Importance of Topic

Monitoring total organic carbon (TOC) is critical for ensuring the purity of water used in pharmaceutical and analytical laboratories. TOC provides a broad assessment of all organic contaminants, reflecting potential threats to product integrity and process safety. Regulatory requirements such as USP 643 and EP 2.2.44 mandate reliable TOC measurement to guarantee water quality for sensitive applications.

Objectives and Overview of the Study

The study examines the ELGA Purelab Pharma Compliance system’s ability to deliver real-time TOC monitoring at the point of dispense. Goals include:

• Validating compliance with USP 643/EP 2.2.44 system suitability test (SST) criteria
• Comparing performance against dedicated TOC analysers over a range of contamination levels
• Demonstrating rapid response at low TOC levels and extended range measurement up to 1000 ppbC

Methodology and Process

The Purelab system uses conductivity detection of CO₂ generated by UV oxidation of organics in purified water. Two modes are employed:

• Low-range real-time mode: single-pass UV oxidation with direct conductivity measurement of CO₂ conversion
• High-range mode: recirculation through the UV chamber via a second pump to extend oxidation capacity and measure up to 1000 ppbC

System suitability testing follows USP 643/EP 2.2.44. Responses to 500 ppbC sucrose and 1,4-benzoquinone solutions are compared against reagent water, with acceptable SST results defined by 85 % ≤ 100·(RSS–RW)/(RS–RW) ≤ 115 %.

Used Instrumentation

• Purelab Pharma Compliance water purifier with integrated TOC monitoring module
• Ultraviolet (UV) oxidation chamber for organic carbon conversion
• Conductivity detector for CO₂ measurement in low-range mode
• Non-dispersive infrared (NDIR) detector option for gas-phase CO₂ in higher concentration scenarios
• Dual-pump configuration enabling variable oxidation cycles

Main Results and Discussion

Validation against two commercial TOC analysers showed agreement within 10 % at 150, 500 and 750 ppbC in high-range mode. Real-time low-range measurements at 5–70 ppbC matched reference analysers within ±15 %. SST trials (ten tests) consistently achieved results between 96 % and 102 %, demonstrating compliance with Pharmacopeia requirements.

Benefits and Practical Applications

Key advantages of the Purelab Pharma Compliance system include:

• Real-time TOC data at point of use, reducing delay between dispense and analysis
• No additional consumables or dedicated oxidisers—simplifying maintenance and lowering operating costs
• Automated mode switching to accommodate wide TOC ranges without manual intervention
• Enhanced laboratory efficiency and assurance of water quality for critical pharmaceutical processes

Future Trends and Opportunities

Emerging directions may include:

• Integration with digital monitoring platforms for remote performance analytics and predictive maintenance
• Optimization of UV oxidation kinetics to further shorten analysis time
• Application of machine-learning algorithms to correlate TOC trends with purifier health and feed-water variability
• Miniaturized sensor modules for point-of-care or decentralized water monitoring

Conclusion

The ELGA Purelab Pharma Compliance system delivers accurate, real-time TOC monitoring that meets USP 643 and EP 2.2.44 requirements without added consumables. Its dual-mode oxidation approach ensures rapid results at low carbon levels and extends measurement capacity up to 1000 ppbC. The system’s ease of maintenance, regulatory compliance and cost efficiency make it a strong candidate for pharmaceutical and high-purity water applications.